Company Information
- Type:
- Company
- Country:
- Egypt
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 28 December 2021 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 30 June 2024
Parent Company
| Country | Company Name |
|---|---|
| United Kingdom | AstraZeneca UK Ltd |
Parent Communication On Progress
| Published On | Title | Level |
|---|---|---|
| 2022-07-18 | 2022 Communication on Progress | Not applicable |
| 2022-06-27 | Communication on Progress | Advanced |
| 2021-03-31 | Communication on Progress 2020 | Advanced |
| 2020-04-03 | Communication on Progress | Advanced |
| 2019-04-04 | Communication on Progress AstraZeneca 2019 | Advanced |
| 2018-04-23 | Communication on Progress | Advanced |
| 2017-04-29 | Communication on Progress | Active |
| 2016-06-06 | Communication on Progress AstraZeneca 2016 | Active |
| 2015-06-10 | AstraZeneca Communication on Progress 2015 | Learner |
| 2015-03-06 | Grace Letter | Not applicable |
| 2014-03-28 | Communication on Progress 2014 | Advanced |
| 2013-03-28 | AstraZeneca 2012 | Advanced |
| 2012-03-28 | 2011 Communication on Progress | Advanced |
| 2011-04-08 | 2010 Communication on Progress | Advanced |
| 2010-12-21 | Grace Letter | Not applicable |